SolyPlus Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Later Stage VC
- Investors
-
3
SolyPlus General Information
Description
Developer of hyaluronic acid and biopolymer products intended to serve medical, pharmaceutical and cosmetic markets. The company's products utilize specialized biopolymer formulations, chemical cross-linking and biocompatibility processing to provide modified hyaluronic acid, active biomaterial bases and custom synthesis, enabling healthcare and cosmetics manufacturers to develop advanced biomaterial applications through specialized manufacturing capabilities.
Contact Information
Website
www.solyplus.comCorporate Office
- Hauptstraße 8
- 25855 Haselund
- Germany
Corporate Office
- Hauptstraße 8
- 25855 Haselund
- Germany
SolyPlus Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 26-Apr-2021 | Completed | Generating Revenue | |||
| 2. Equity Crowdfunding | 17-Nov-2020 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Jan-2020 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
SolyPlus Patents
SolyPlus Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3202259-A1 | Means and methods of preventing, treating and detecting infections | Pending | 22-Dec-2020 | ||
| EP-4267148-A1 | Means and methods of preventing, treating and detecting infections | Pending | 22-Dec-2020 | ||
| US-20240050366-A1 | Means and methods of preventing, treating and detecting infections | Pending | 22-Dec-2020 | ||
| WO-2022135767-A1 | Means and methods of preventing, treating and detecting infections | Inactive | 22-Dec-2020 | ||
| CA-3171226-A1 | Means and methods of preventing and treating infections | Pending | 15-Apr-2020 | A61K31/722 |
SolyPlus Signals
SolyPlus Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Förde Ventures | Venture Capital | Minority | ||
| MBG Schleswig-Holstein | PE/Buyout | Minority | ||
| Seed and Startup Fund Schleswig-Holstein | Venture Capital | Minority |
SolyPlus FAQs
-
When was SolyPlus founded?
SolyPlus was founded in 2016.
-
Where is SolyPlus headquartered?
SolyPlus is headquartered in Haselund, Germany.
-
What is the size of SolyPlus?
SolyPlus has 5 total employees.
-
What industry is SolyPlus in?
SolyPlus’s primary industry is Specialty Chemicals.
-
Is SolyPlus a private or public company?
SolyPlus is a Private company.
-
What is SolyPlus’s current revenue?
The current revenue for SolyPlus is .
-
How much funding has SolyPlus raised over time?
SolyPlus has raised $599K.
-
Who are SolyPlus’s investors?
Förde Ventures, MBG Schleswig-Holstein, and Seed and Startup Fund Schleswig-Holstein have invested in SolyPlus.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process